Edition:
United States

Profile: Akers Biosciences Inc (AKR.L)

AKR.L on London Stock Exchange

130.00GBp
--
Change (% chg)

0.00 (+0.00%)
Prev Close
130.00
Open
130.00
Day's High
--
Day's Low
--
Volume
0
Avg. Vol
3,781
52-wk High
255.00
52-wk Low
86.00

Akers Biosciences, Inc. develops, manufactures and supplies point-of-care screening and testing products designed to bring health-related information to the patient or clinician. The Company's product offerings and pipeline products focus on delivering diagnostic assistance in a range of healthcare fields/specialties, including cardiology/emergency medicine, metabolism/nutrition, diabetes, respiratory diseases and infectious diseases detection, as well as for on and off-the-job alcohol safety initiatives. The Company's primary focus is the development and sale of disposable diagnostic testing devices that can be performed in minutes, to facilitate time sensitive therapeutic decisions. The Company's main products include a disposable breathalyzer test that measures the blood alcohol content of the user, a rapid test detecting the antibody causing an allergic reaction to Heparin and a disposable breathalyzer test that measures Free Radical activity in the human body.

Company Address

Akers Biosciences Inc

201 Grove Rd
WEST DEPTFORD   NJ   08086-2231
P: +1856.8488698

Company Web Links